Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting Pediatric Cancer Stem Cells With Oncolytic Virotherapy

Pediatric Research
Child HealthPediatricsPerinatology
2012English

Preclinical Evaluation of Exemestane as a Novel Chemotherapy for Gastric Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances

Oncolytic Virotherapy
2015English

Preclinical Testing of a Novel Personalized Cancer Vaccine for All Solid Tumors and All Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Preclinical Approaches for Drugs Targeting Cognitive Deficits of Schizophrenia

Folia Pharmacologica Japonica
Pharmacology
2010English

An Organoid Based Preclinical Model of Human Gastric Cancer

Cellular and Molecular Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis

ACS Nano
Materials ScienceNanoscienceEngineeringNanotechnologyAstronomyPhysics
2015English

Preclinical Evaluation of the Enceliacanescens Lam Extract: Medicinal Properties Useful for Cancer Treatment

Journal of Natural Remedies
Pharmacology
2015English

Preclinical Evaluation of a Nanoformulated Antihelminthic, Niclosamide, in Ovarian Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy